Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?
Open Access
- 13 August 2004
- journal article
- review article
- Published by S. Karger AG in Heart Drug
- Vol. 4 (3) , 123-130
Abstract
Within the last two decades, hemostasis factors have emerged as ‘new’ risk factors for coronary artery disease. Historical studies on the physiology of the sympathetic nervous system (SNS) attributed accelerated blood clotting to the components of the fight-flight response. Although this has not been demonstrated, exaggerated clotting related to SNS hyperactivity might confer an increased arterial thrombotic risk. This review outlines the effects of sympathetic activation as mimicked by adrenergic infusions and as elicited by mental stress and physical exercise, and the molecular mechanisms involved. A selective review of the pertinent literature was undertaken. Sympathetic activation provokes a simultaneous increase in molecules of both the coagulation and fibrinolysis pathways within minutes, resulting in net hypercoagulability as a part of normal human physiology. Catecholamines and adrenergic receptors interact to mediate hemostatic changes. Exaggerated procoagulant changes in individuals with a preexistent atherosclerotic disease, in those experiencing ongoing stressful life circumstances and in the physically untrained might confer a thrombotic threat with sympathetic activation. Initial evidence suggests that nonselective β-adrenergic blockade may attenuate clotting acceleration upon SNS activation. Prospective studies are needed to demonstrate whether exaggerated clotting as elicited by the SNS is associated with an increased risk of cardiovascular morbidity and mortality. If confirmed, intervention studies targeted at reducing this risk, for example with drugs, psychotherapy (including stress management) and regular physical exercise, would be warranted.Keywords
This publication has 53 references indexed in Scilit:
- Hemostatic Alterations in Patients With Obstructive Sleep Apnea and the Implications for Cardiovascular Disease *Chest, 2003
- Effects of strenuous exercise on haemostasis: Table 1British Journal of Sports Medicine, 2003
- Fibrin fragment D-dimer and the risk of future venous thrombosisBlood, 2003
- Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parametersThrombosis and Haemostasis, 2003
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Sense of exhaustion and coronary heart disease among college alumni∗∗This is report no. LXXIV in a series on chronic disease in former college students.The American Journal of Cardiology, 1999
- Epinephrine Exerts Anticoagulant Effects during Human EndotoxemiaJournal of Experimental Medicine, 1997
- Association of Chronic Stress With Plasminogen Activator Inhibitor–1 in Healthy Middle-aged MenArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Role of thrombosis in atherosclerosis and its complicationsThe American Journal of Cardiology, 1995
- Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertensionJournal Of Hypertension, 1988